- StratCare Trial 2: Evaluating the Clinical and Cost-effectiveness of AI-driven Stratified Care for Depression — Recruiting • Non-phase study • Gastroenterology • NCT06567340.
- What is being tested: An AI-driven stratified care approach for depression that aims to match patients to the most appropriate treatment intensity from the outset, compared to the standard stepped care model where patients typically start with brief interventions.
- Patient eligibility overview: Adults with depression and/or anxiety presenting in primary care settings across the UK; the trial evaluates whether personalised treatment allocation based on AI stratification improves outcomes across diverse patient populations.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
Depression and anxiety are common mental health problems affecting around one in six adults. Treatments include therapy, telephone or group-based activities delivered by therapists. Treatment uses a "stepped care" model where most patients start with very brief treatments. If they remain unwell after this, they access longer and more intensive therapy. This model does not always work, as only one out of two patients fully recover. The researchers have developed an artificial intelligence tool called "StratCare". It is designed to help health services to offer the best available treatment for…
- In addition to the criteria, participants must be under the treatment of a participating Talking Therapies service. Inclusion criteria: * 18 years of age or older. * Patients who consent to share their de-identified clinical records for research purposes. * Patients assessed as eligible for psychological care in Talking Therapies based on clinical guidelines. * Patients with case-level depression symptoms (PHQ-9 ≥ 10).
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.